Journal Name: International Journal of Renal Diseases and Therapy
ISSN: 2631-3685
DOI: 10.31021
Indexing: Click Here
Journal Type: Open Access
Contact Us: Click Here
The International Journal of Renal Diseases and Therapy (IJRDT) is an international, peer-reviewed, open access journal published by Boffin Access Limited. The journal is dedicated to advancing scientific knowledge and clinical practice in nephrology, dialysis, renal transplantation, and innovative therapies for kidney-related disorders.
As kidney diseases continue to be a global health challenge, IJRDT provides a reliable platform for researchers, clinicians, and healthcare professionals to publish high-quality work that drives progress in diagnosis, treatment, and prevention of renal diseases.
The journal welcomes a wide range of contributions including original research articles, reviews, case reports, short communications, and clinical studies. Areas of interest include, but are not limited to:
Chronic Kidney Disease (CKD) and Acute Kidney Injury (AKI)
Dialysis techniques, innovations, and patient care
Renal transplantation, immunosuppression, and graft survival
Hypertension, diabetes, and metabolic syndromes affecting the kidneys
Renal physiology, pathology, and molecular mechanisms
Glomerular and tubular disorders
Pediatric nephrology and congenital kidney diseases
Biomarkers and novel diagnostics in nephrology
Pharmacology and therapeutics in renal care
Preventive nephrology and public health strategies
Global Visibility – Open access publication ensures broad dissemination to nephrologists, clinicians, and researchers worldwide.
Rigorous Peer Review – Manuscripts undergo double-blind peer review for fairness and scientific merit.
Rapid Publication – Accepted articles are published promptly to accelerate knowledge exchange.
Clinical and Translational Impact – The journal bridges laboratory findings with clinical practice, enhancing patient care outcomes.
Expert Editorial Board – Guided by international experts in nephrology, renal therapy, and transplantation.
Author Benefits – Authors retain copyright under Creative Commons licensing, maximizing citation and reuse opportunities.
Diverse Article Formats – Supports publication of case reports, reviews, original studies, and clinical trial data.
The International Journal of Renal Diseases and Therapy follows globally recognized best practices, adhering to COPE and ICMJE guidelines. Editorial decisions are based solely on scientific merit, ethical standards, and clinical relevance, ensuring trust and transparency in every publication.
SCINEXI is committed to upholding the integrity and credibility of the scholarly record. In accordance with international publishing ethics, articles may be retracted when found to contain serious errors, evidence of research misconduct, copyright infringement, or plagiarism. Retraction is a necessary step to safeguard academic reliability and to ensure that the literature remains a trustworthy resource for the global research community.
If you wish to report a concern regarding any published article, please share the details with us by clicking below:
Send Information
Stay connected with SCINEXI. Enter your e-mail address to receive alerts on newly published articles, special issue announcements, and the latest updates from our journals.
At SCINEXI, we actively welcome feedback and constructive criticism. Your compliments, concerns, and suggestions help us refine our services and elevate the author and reader experience.
Have an idea that could advance the Open Access community? We’d love to hear it. Please write to: support@scinexi.com
Copyright © 2025 BOFFIN ACCESS.